Intestinal Barrier Markers – Definition & Diagnostics
Intestinal barrier markers are laboratory values that assess the integrity of the gut lining and are used when increased intestinal permeability, or leaky gut, is suspected.
Things worth knowing about "Intestinal barrier markers"
Intestinal barrier markers are laboratory values that assess the integrity of the gut lining and are used when increased intestinal permeability, or leaky gut, is suspected.
What are intestinal barrier markers?
Intestinal barrier markers are specific laboratory parameters used to evaluate the function and integrity of the intestinal mucosa – the lining of the gut. The gut lining acts as a selectively permeable protective barrier between the intestinal lumen and the bloodstream. When this barrier is compromised, bacteria, toxins, and undigested food particles can enter the circulation – a condition known as increased intestinal permeability or, colloquially, leaky gut.
Clinical relevance
A damaged intestinal barrier has been associated with a wide range of conditions, including:
- Inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis)
- Irritable bowel syndrome (IBS)
- Food intolerances and allergies
- Autoimmune diseases
- Metabolic syndrome and obesity
- Systemic inflammatory responses (sepsis)
By measuring intestinal barrier markers, clinicians can detect early signs of compromised barrier function and initiate targeted therapeutic measures.
Key intestinal barrier markers
Zonulin
Zonulin is a protein that regulates the opening of tight junctions – the sealing connections between intestinal epithelial cells. Elevated zonulin levels in blood or stool are considered an indicator of increased intestinal permeability. Raised levels are frequently found in patients with celiac disease, inflammatory bowel disease, and type 1 diabetes mellitus.
Alpha-1-antitrypsin (A1AT) in stool
Alpha-1-antitrypsin is a plasma protein that is not normally secreted into the gut in significant quantities. Elevated fecal A1AT indicates pathological protein loss through the gut mucosa, known as protein-losing enteropathy, and is a well-established marker of intestinal barrier damage.
Fatty acid-binding protein 2 (FABP2 / I-FABP)
Intestinal fatty acid-binding protein (I-FABP) is produced exclusively in enterocytes (intestinal epithelial cells). When these cells are injured or destroyed, I-FABP is released into the bloodstream. Elevated serum levels are a sensitive indicator of acute intestinal mucosal damage, such as in ischemia, sepsis, or severe inflammation.
Fecal calprotectin
Calprotectin is a protein found mainly in neutrophil granulocytes (immune cells). Elevated fecal calprotectin signals inflammation of the intestinal mucosa and is widely used to differentiate between organic bowel diseases (e.g., Crohn's disease) and functional disorders (e.g., IBS).
Lipopolysaccharide-binding protein (LBP)
LBP is an acute-phase protein that binds to lipopolysaccharides (LPS) – components of the cell wall of gram-negative bacteria. Elevated blood LBP levels may indicate increased translocation of bacterial components from the gut into the bloodstream, a process referred to as bacterial translocation.
Diagnosis and testing
Intestinal barrier markers are measured either in blood (serum) or in stool, depending on the specific marker. Analysis is performed in specialized laboratories using immunological methods such as ELISA. In addition, intestinal permeability can be assessed using functional tests such as the lactulose-mannitol test, in which both sugars are ingested orally and their urinary ratio is subsequently measured.
Treatment options for impaired intestinal barrier function
When increased intestinal permeability is identified, several therapeutic approaches may help restore barrier integrity:
- Dietary changes: Reducing sugar, alcohol, and highly processed foods; gluten-free diet in celiac disease
- Probiotics and prebiotics: Supporting a healthy gut microbiome
- L-glutamine: An amino acid that serves as a key energy source for intestinal cells
- Zinc: Contributes to stabilizing tight junctions
- Treatment of the underlying condition: e.g., pharmacological therapy for Crohn's disease or ulcerative colitis
- Stress reduction: Chronic stress can negatively affect the intestinal barrier
References
- Fasano, A. (2012): Leaky gut and autoimmune diseases. Clinical Reviews in Allergy & Immunology, 42(1), 71–78. doi:10.1007/s12016-011-8291-x
- Camilleri, M. (2019): Leaky gut: mechanisms, measurement and clinical implications in humans. Gut, 68(8), 1516–1526. doi:10.1136/gutjnl-2019-318427
- Turner, J. R. (2009): Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology, 9(11), 799–809. doi:10.1038/nri2653
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryCortisol kinetics analysis
Mitochondrial stimulation
Osteolysis
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Intestinal barrier markers